iQ3Corp Ltd. announced that a previously ratified agreement, which mandated iQ3Corp to act as lead manager, corporate advisor and to capital raise for Clinical Research Corporation Pty Ltd. (CRC) pre-Initial Public Offering (IPO), has now been extended to cover the IPO. More specifically, iQ3 will now be acting as lead manager and corporate advisor for the IPO, conducting the IPO capital raising and managing the underwriting of the offer.